CD8A and neoplasm: As an increase in the number of tumor-infiltrating CD8+ T cells improves clinical outcome of human colorectal cancer1, 22, 23, 24, it is possible that tumor-infiltrating T cell deletion with apoptosis imposes immune dysfunction.